Overview

Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.

Status:
Terminated
Trial end date:
2009-06-10
Target enrollment:
Participant gender:
Summary
The Purpose of this trial is to evaluate the use of a cross-over trial design in an osteoarthritis population. We will determine the inter- and intra-subject variability in osteoarthritis (OA) endpoints and evaluate if efficacy can be detected by measuring OA endpoints following treatment with 2 different types of analgesics in a crossover study of this design.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Celecoxib
Oxycodone